// App-Quantinova.ai

244 : Conventional immunotherapy vs nano‐vaccination in high risk allergy

Researchers

Presenter

  • Kramer MF

Principal Investigators

  • Heath

  • Skinner MA

  • Carreo TL

Medical Centers

  • Allergy Therapeutics Ltd, Worthing, United Kingdom

  • Bencard Allergie Gmbh, Munich, Germany

  • Bencard Adjuvant Systems, Worthing, United Kingdom

Locations

  • United Kingdom

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A